G42 Healthcare and AstraZeneca will work closely together to explore real-world evidence and conduct clinical trials through IROS – the first-of-its-kind Contract Research Organization (CRO) in the UAE
Neutralising antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant
The company will manufacture a cancer immunotherapy product from 2022
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
The division is expected to grow to over a 100-member strong team by 2022
Rajiv Gandhi Cancer Institute (RGCI), Delhi one of Asia’s premier institutes becomes the first strategic partner to adopt and implement Project Chariot in patients across North India & Delhi NCR region
Subscribe To Our Newsletter & Stay Updated
